Guangxi Wuzhou Zhongheng Group Company Description

Guangxi Wuzhou Zhongheng Group Co., Ltd, together with its subsidiaries, researches, develops, manufactures, and sells pharmaceuticals in China.

The company offers traditional Chinese medicine, including Xueshuantong injection, Zhonghua Dieda Wan for traumatic injuries, Fuyanjing capsules, JieShiTong tablets, snake gall and fritillaria liquid, Kunyuean granules, and compound clam oral liquid for cardiovascular and cerebrovascular, neurology, endocrinology, orthopedics, ophthalmology, gynecology, pediatrics, respiratory, urinary system, and other healthcare applications.

It also provides clindamycin hydrochloride injection, esomeprazole sodium injection, esomeprazole magnesium enteric-coated capsules, cefoperazone dry suspension, naloxone hydrochloride injection, and fludarabine phosphate injection.

Further, the company is involved in production of oral care, clothing care, and home care products, including toothpaste; health food business; pharmaceutical distribution; project investment and management; real estate development and operation; and cosmetic products businesses.

Guangxi Wuzhou Zhongheng Group Co., Ltd was founded in 1993 and is based in Wuzhou, China.

Guangxi Wuzhou Zhongheng Group Co., Ltd

Country	China
Founded	1993
Industry	Drug Manufacturers - Specialty & Generic
Sector	Healthcare
Employees	2,971
CEO	Yidong Ni

Contact Details

Address: No. 1 Industrial Avenue Wuzhou, 543000 China
Phone	86 77 1274 2275
Website	wz-zhongheng.com

Stock Details

Ticker Symbol	600252
Exchange	Shanghai Stock Exchange
Fiscal Year	January - December
Reporting Currency	CNY
ISIN Number	CNE0000015F9
SIC Code	2834

Key Executives

Name	Position
Hai Run Wang	Deputy GM, General Counsel, Secretary, Chief Compliance Officer and Director
Weimin Peng	Deputy General Manager
Ming Chen	Deputy General Manager
Xiangyong Wang	Deputy General Manager
Lin Xiao	Deputy General Manager
Hui Ge	Financial Officer
Peng Li	Accounting Supervisor
Tian Jiao Wang	Deputy General Manager